We came across a bullish thesis on Journey Medical Corporation (DERM) on Substack by The 10x Radar. In this article, we will ...

Salesforce's growth potential remains strong with focus on cost control, AI expansion, and shareholder value. Discover why CRM offers ~25% upside.

In a report released today, Daniel Ives from Wedbush maintained a Buy rating on Salesforce (CRM – Research Report), with a price target of ...

Amanda Butler, chief technology officer of Nepsis, said she has been working for over a decade to help the firm integrate its ...

Salesforce (CRM) is set to report fiscal fourth-quarter results on Feb. 26 and Wedbush Securities believes it has become a ...